| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $27,3000 | +2,98% | $1,74B | $353,06K | |
SGRY Surgery Partners, Inc. Common Stock | $13,5850 | -1,34% | $1,74B | $851,70K | |
GAB The Gabelli Equity Trust Inc. | $5,6050 | -0,27% | $1,74B | $675,44K | |
HURN Huron Consulting Group Inc. | $104,31 | -2,16% | $1,74B | $130,20K | |
ENVX Enovix Corporation Common Stock | $8,2450 | -4,35% | $1,74B | $5,28M | |
PAYO Payoneer Global Inc. Common Stock | $5,0350 | -5,89% | $1,74B | $3,20M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9100 | -0,27% | $1,73B | $152,26K | |
STGW Stagwell Inc. Class A Common Stock | $6,5950 | -8,40% | $1,73B | $1,29M | |
CASH Pathward Financial, Inc. Common Stock | $78,4600 | -3,62% | $1,73B | $190,58K | |
SNDX Syndax Pharmaceuticals, Inc. | $18,3300 | -0,33% | $1,73B | $610,15K | |
STRA Strategic Education, Inc. Common Stock | $78,3600 | -1,01% | $1,73B | $103,02K | |
CAPR Capricor Therapeutics Inc | $27,4110 | +0,26% | $1,73B | $434,40K | |
AAPG Ascentage Pharma Group International American Depository Shares | $17,8250 | -3,39% | $1,73B | $20,67K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,1850 | -1,74% | $1,73B | $6,35M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $24,9250 | +2,66% | $1,73B | $162,12K | |
